Two Sigma Investments’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$216K	Buy	+181,172	New	+$216K	﹤0.01%	2844
2023 Q1	–	Sell	-21,534	Closed	-$248K	–	2847
2022 Q4	$248K	Buy	+21,534	New	+$248K	﹤0.01%	2258